0SAN.L
SANDOZ GROUP AG SANDOZ GROUP OR
£65.59
+0.40%
2026-05-29
About SANDOZ GROUP AG SANDOZ GROUP OR
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
Key Fundamentals
ROE
10.4%
Revenue Growth (YoY)
10.7%
Profit Margin
8.2%
Debt/Equity
60.73
Price/Book
3.84
Beta
0.53
Avg Volume (10D)
244K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
£69.24
60D Low
£57.60
Avg Volume
268K
Latest Close
£65.59
Get breakout alerts for 0SAN.L
Sign up for Breakout Scanner to receive daily notifications when 0SAN.L triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
SANDOZ GROUP AG SANDOZ GROUP OR (0SAN.L) is listed on the London Stock Exchange (LSE). Breakout Scanner monitors 0SAN.L daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups.. Data is provided for informational purposes only and does not constitute financial advice.